Annals of medicine · 2025
Impact of nonpharmaceutical interventions on inflammatory diseases of the nose.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dai Lili, Liu Shuhan, Chen Liwei, Fan Xiaofeng, Wang Sirui, Ding Yawen, Yi Xiangwei, Cheng Yongran
Аннотация
AIM: This study aimed to investigate the impact of nonpharmaceutical interventions (NPIs), implemented by the Chinese government during 2020-2022 to reduce the spread of coronavirus disease 2019, on the incidence of inflammatory nasal diseases, including chronic nonallergic rhinitis, allergic rhinitis, acute rhinitis, chronic sinusitis and acute sinusitis.
METHODS: Medical records from the Department of Otorhinolaryngology of the Hangzhou Normal University Affiliated Hospital were analysed to compare the incidence of the five nasal diseases between the pre-pandemic (January 2018-December 2019) and the pandemic prevention periods (January 2020-December 2022). The Chi-square test was used to compare incidence rates and sex/age distributions.
RESULTS: The incidence of chronic nonallergic rhinitis, chronic sinusitis and acute sinusitis decreased significantly during the pandemic prevention period (p < .001), while the incidence of allergic rhinitis and acute rhinitis increased significantly (p < .001). NPIs were protective factors for chronic nonallergic rhinitis, chronic rhinosinusitis and acute rhinosinusitis (relative risk (RR) < 1) but risk factors for allergic rhinitis and acute rhinitis (RR > 1). The proportion of male patients increased significantly for chronic nonallergic rhinitis and chronic sinusitis (p < .001). The age of the patients showed significant differences in the four diseases - chronic nonallergic rhinitis, allergic rhinitis, chronic sinusitis and acute sinusitis (p < .001).
CONCLUSIONS: NPIs had a significant impact on the incidence and epidemiology of nasal inflammatory diseases, with significant differences in incidence rate, sex and age distribution between the pre-pandemic and pandemic prevention periods.
METHODS: Medical records from the Department of Otorhinolaryngology of the Hangzhou Normal University Affiliated Hospital were analysed to compare the incidence of the five nasal diseases between the pre-pandemic (January 2018-December 2019) and the pandemic prevention periods (January 2020-December 2022). The Chi-square test was used to compare incidence rates and sex/age distributions.
RESULTS: The incidence of chronic nonallergic rhinitis, chronic sinusitis and acute sinusitis decreased significantly during the pandemic prevention period (p < .001), while the incidence of allergic rhinitis and acute rhinitis increased significantly (p < .001). NPIs were protective factors for chronic nonallergic rhinitis, chronic rhinosinusitis and acute rhinosinusitis (relative risk (RR) < 1) but risk factors for allergic rhinitis and acute rhinitis (RR > 1). The proportion of male patients increased significantly for chronic nonallergic rhinitis and chronic sinusitis (p < .001). The age of the patients showed significant differences in the four diseases - chronic nonallergic rhinitis, allergic rhinitis, chronic sinusitis and acute sinusitis (p < .001).
CONCLUSIONS: NPIs had a significant impact on the incidence and epidemiology of nasal inflammatory diseases, with significant differences in incidence rate, sex and age distribution between the pre-pandemic and pandemic prevention periods.